Fuzapladib Sodium

327 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

327

Total Reports

125

Deaths Reported

3820.0%

Death Rate

Active Ingredients

Fuzapladib Sodium

Administration Routes

IntravenousUnknownSubcutaneousParenteralIntradermal

Species Affected

Dog 308

Unknown 15

Cat 2

Human 2

Most Affected Breeds

Crossbred Canine/dog 70

Terrier - Yorkshire 26

Unknown 26

Dog (unknown) 19

Mixed (Dog) 12

Chihuahua 10

Dachshund (unspecified) 10

Shih Tzu 9

Boxer (German Boxer) 7

Retriever - Labrador 5

Most Reported Reactions

Death by euthanasia 81

Lack of efficacy - NOS 45

Vomiting 35

Elevated total bilirubin 34

Abnormal ultrasound finding 31

Anorexia 30

Elevated serum alkaline phosphatase (ALP) 28

Death 28

Lethargy (see also Central nervous system depression in Neurological) 26

Icterus 25

Diarrhoea 24

Neutrophilia 20

Outcome Breakdown

Ongoing

129 (41.3%)

Euthanized

80 (25.6%)

Recovered/Normal

46 (14.7%)

Died

45 (14.4%)

Outcome Unknown

12 (3.8%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.